There are three EQ-5D value sets available for use in cost effectiveness analysis in the UK and/or England:

- the UK EQ-5D-3L value set (often called the ‘MVH’ value set) which has been used for two decades, e.g. in evidence submitted to NICE (Dolan, 1997);
- a ‘crosswalk’ value set (van Hout et al., 2012), which maps patients’ EQ-5D-5L data to the EQ-5D-3L descriptive system, so that the MVH value set can be applied; and
- the EQ-5D-5L value set for England (Devlin et al., 2016).

How do these value sets differ? And how important are these differences likely to be for users?

A new OHE Research Paper by Mulhern et al. (2017) compares the characteristics of the value sets.

OHE’s Professor Nancy Devlin and co-author Richard Brooks have published a new paper that provides an overview of the development of the EQ-5D; the current state of play; and what the future might hold for the further development and use of EQ-5D instruments in HTA and other applications.